Menu
Back to Journals » International Journal of Nanomedicine » Volume 11
Original Research
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 8,111 | Dovepress* | 4,120 | 3,035+ | 1,125 | 7,155 |
| PubMed Central* | 0 | 956 | 283 | 956 | |
| Totals | 4,120 | 3,991 | 1,408 | 8,111 | |
|
*Since 8 January 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 4 | 4 |
View citations on PubMed Central and Google Scholar